Opinions
Jim Cramer - Mad Money
23andMe
ME-Q
BUY ON WEAKNESS
Jul 11, 2022
He's shocked this is so low. Glaxo should buy them. At $2, the risk is priced in. Buy.
$2.830
Stock price when the opinion was issued
Healthcare
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
BUY
It's a genetic testing company with subscription services to let you know how your genes could effect your health. They went public last June, but has fallen since from $11 to $8. He doesn't understand why. Gene sequencing is the future of medicine and this company holds a treasure trove of data (kept private) that could be applied in medicine.
Healthcare
Advertising